Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine

References

1. Baer G. M., Brooks R. C., Foggin C. M. 1989; Oral vaccination of dogs fed canine adenovirus in baits. American Journal of Veterinary Research 50:836–837
   [Google Scholar]
2. Ballay A., Levrero M., Buendia M. A., Tiollais P., Perricaudet M. 1985; In vitro and in vivo synthesis of the hepatitis B surface antigen and of the receptor for polymerised human serum albumin from recombinant human adenoviruses. EMBO Journal 4:3861–3865
   [Google Scholar]
3. Ballay A., Levrero M., Tiollais P., Perricaudet M. 1987; A hepatitis B adenovirus recombinant as a potential live vaccine. In Hepadnaviruses. UCLA Symposia on Molecular and Cellular Biology, New Series 70 pp 481–493 Robinson W., Koike K., Will H. Edited by New York: Alan R. Liss;
   [Google Scholar]
4. Berget S. M., Moore C., Sharp P. 1977; Spliced RNA segments at the 5ʹ terminus of adenovirus 2 late mRNA. Proceedings of the National Academy of Sciences U.S.A.: 743171–3175
   [Google Scholar]
5. Berkner K. L. 1988; Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6:616–629
   [Google Scholar]
6. Betts A. O., Jennings A. R., Lamont P. H., Page Z. 1962; Inoculation of pigs with adenoviruses of man. Nature; London: 19345–46
   [Google Scholar]
7. Chappuis G., Fargeaud D., Brun A. 1989; Industrial production and control of a subunit vaccine against Aujeszkyʹs disease. In Vaccination and Control of Aujeszkyʹs Disease pp 67–78 Van Oirschot J. T. Edited by Brussels & Luxembourg: ECSC, EEC, EAEC;
   [Google Scholar]
8. Dermott M. R., Graham F. L., Hanke T., Johnson D. C. 1989; Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glyco-protein B. Virology 169:244–247
   [Google Scholar]
9. Eloit M., Fargeaud D., LʹHaridon R., Toma B. 1988; Identification of the pseudorabies glycoprotein gp50 as a major target of neutralizing antibodies. Archives of Virology 99:45–56
   [Google Scholar]
10. Eloit M., Fargeaud D., Vannier P., Toma B. 1989; Development of an ELISA test to differentiate between animals either vaccinated with or infected by Aujeszkyʹs disease virus. Veterinary Record 124:91–94
    [Google Scholar]
11. Ghosh-Choudhury G., Haj-Ahmad Y., Graham F. L. 1987; Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO Journal 6:1733–1739
    [Google Scholar]
12. Graham F. L., Van Der Eb A. J. 1973; A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467
    [Google Scholar]
13. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
14. Grand R. J. A. 1987; The structure and functions of the adenovirus early region I proteins. Biochemical Journal 241:25–38
    [Google Scholar]
15. Ishii H., Kobayashi Y., Kuroki M., Kodama Y. 1988; Protection of mice from lethal infection with Aujeszkyʹs disease virus by immunization with purified gVI. Journal of General Virology 69:1411–1414
    [Google Scholar]
16. Johnson D. C., Ghosh-Choudhury G., Smiley J. R., Fallis L., Graham F. L. 1988; Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164:1–14
    [Google Scholar]
17. Kost T. A., Jones E. V., Smith K. M., Reed A. P., Brown A. L., Miller J. J. 1989; Biological evaluation of glycoproteins mapping to two distinct mRNAs within the Bam HI fragment 7 of pseudorabies virus: expression of the coding region by vaccinia virus. Virology 171:365–376
    [Google Scholar]
18. Levrero M., Ballay A., Schellekens H., Tiollais P., Perricaudet M. 1988; Hepatitis B adenovirus recombinant as a potential live vaccine. In Proceedings oj the 8th International Biotechnology Symposium, Paris pp 702–712 Durand G., Bobichon L., Durand L., Florent J. Edited by
    [Google Scholar]
19. Lubeck M. D., Davis A. R., Chengalva M., Natuk R. J., Morin J. E., Molnar-Kimber K., Mason B. B., Bhat B. M., Mizutani S., Hung P. P., Purcell R. H. 1989; Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proceedings of the National Academy of Sciences U.S.A.: 866763–6767
    [Google Scholar]
20. Marchioli C. C., Yancey R. J., Petrovskis E. A., Timmins J. G., Post L. E. 1987; Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszkyʹs disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells. Journal of Virology 61:3977–3982
    [Google Scholar]
21. Morin J. E., Lubeck M. P., Barton J. E., Conley A. J., Davis A. R., Hung P. P. 1987; Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proceedings of the National Academy of Sciences U.S.A.: 844626–4630
    [Google Scholar]
22. Murphy F. A. 1989; Vaccinia-vectored vaccines-risks and benefits. Research in Virology 140:463–491
    [Google Scholar]
23. Nevins J. R. 1987; Regulation of early adenovirus gene expression. Microbiological Reviews 51:419–430
    [Google Scholar]
24. Petrovskis E. A., Timmins J. G., Armentrout M. A., Marchioli C. C., Yancey R. J., Post L. E. 1986; DNA sequence of the gene for pseudorabies virus gp50, a glycoprotein without V-linked glycosylation. Journal of Virology 59:216–223
    [Google Scholar]
25. Prevec L., Schneider M., Rosenthal K. L., Belbeck L. W., Derbyshire J. B., Graham F. L. 1989; Use of human adenovirus-based vectors for antigen expression in animals. Journal of General Virology 70:429–434 erratum 2539
    [Google Scholar]
26. Schneider M., Graham F. L., Prevec L. 1989; Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. Journal of General Virology 70:417–427
    [Google Scholar]
27. Shenk T., Williams J. 1984; Genetic analysis of adenovirus. Current Topics in Microbiology and Immunology 111:1–39
    [Google Scholar]
28. Sumner J. W., Shaddock H. H., Wu G., Baer G. M. 1988; Oral administration of an attenuated strain of canine adenovirus (type 2) to raccoons, foxes, skunk, and mongoose. American Journal of Veterinary Research 49:169–171
    [Google Scholar]
29. Thummel C., Than R., Hu S. H., Grodzicker T. 1983; Translational control of adenovirus late promoter. Cell 33:455–464
    [Google Scholar]
30. Wathen L. M. K., Plat K. B., Wathen M. W., Van Densen R. A., Whestone C. A., Pirtle E. C. 1985; Production and characterization of monoclonal antibody directed against pseudorabies virus. Virus Research 4:19–29
    [Google Scholar]